Maternal Kidney Disease Increases Congenital Malformation Risk in Offspring

A significant nationwide cohort study, recently highlighted by the European Medical Journal, has established a clear link between maternal kidney disease and an increased risk of congenital malformations in newborns. The study, published in Communications Medicine on February 8, 2026, analyzed data from over 2.6 million births in Korea between 2008 and 2017, utilizing the Korean National Health Insurance Service database. The research aimed to clarify the association between maternal kidney disease, encompassing both chronic kidney disease (CKD) and end-stage kidney disease (ESKD), and the likelihood of major congenital anomalies in offspring, an area where previous evidence had been somewhat limited or focused on specific types of malformations or confounding factors. The findings demonstrate that babies born to mothers with kidney disease face a modestly increased risk of congenital malformations. Specifically, the prevalence of major congenital malformations was found to be 4.79% among infants born to healthy mothers. This rate saw a slight increase to 5.29% in offspring of mothers with chronic kidney disease (CKD) and a more marked rise to 9.65% in those whose mothers had end-stage kidney disease (ESKD). Congenital heart defects were identified as the most frequently reported anomalies across all groups, suggesting a particular vulnerability in cardiac development. After accounting for various potential confounding factors, maternal kidney disease remained independently associated with an elevated risk of congenital malformations. Mothers with CKD exhibited a statistically significant, albeit small, increase in risk, with an adjusted odds ratio (aOR) of 1.07 (95% CI 1.03–1.11) compared to healthy controls. The risk was substantially higher for mothers with ESKD, showing an aOR of 1.71 (95% CI 1.16–2.52). Within the ESKD subgroup, women who had received a kidney transplant also showed an elevated risk (aOR 1.65; 95% CI 1.06–2.59), whereas the association did not reach statistical significance among those undergoing dialysis in this particular study. This study's findings are particularly relevant given the growing number of pregnancies among women with chronic medical conditions, including kidney disease. Chronic kidney disease can negatively impact the physiological adaptations necessary for a healthy pregnancy, leading to various adverse maternal and fetal outcomes such as gestational hypertension, pre-eclampsia, fetal growth restriction, and preterm delivery. Earlier research has also indicated that pregnancy in CKD is considered high-risk, with elevated rates of adverse maternal and fetal outcomes, including miscarriage, preterm delivery, and fetal death. Other studies further corroborate the association between maternal chronic diseases and congenital anomalies. For instance, a Japanese cohort study found that maternal kidney disease was associated with an elevated risk of isolated congenital anomalies of the kidney and urinary tract (CAKUT). Similarly, another cohort study indicated that maternal chronic diseases, including kidney disease and gestational diabetes, were risk factors for CAKUT. These broader findings reinforce the importance of managing pre-existing maternal health conditions. The implications of these findings for healthcare professionals are significant. The study underscores the necessity for comprehensive pre-conception counseling and meticulous antenatal care for women with kidney disease. A multidisciplinary approach, involving nephrologists, obstetricians, and pediatricians, is essential to monitor these pregnancies closely, manage comorbidities like hypertension which are common in CKD and can further complicate pregnancy, and provide timely interventions to mitigate risks for both mother and child. While interventions like dialysis and transplantation can reduce some risks, complication rates remain higher compared to normal pregnancies, necessitating sustained vigilance. For an audience in India, where the prevalence of chronic diseases is rising, these findings are highly relevant. Early detection, effective management of maternal kidney disease, and robust prenatal screening programs can play a crucial role in improving fetal outcomes and reducing the incidence of congenital malformations. Public health initiatives should focus on raising awareness among women of reproductive age about the potential risks associated with kidney disease during pregnancy and encourage proactive health management. The study's emphasis on even a modest increase in risk for CKD highlights that even milder forms of kidney impairment warrant careful attention in pregnant individuals.

Frequently Asked Questions

Read Full Story on Quick Digest